These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1919624

  • 1. Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.
    Hainsworth JD, Andrews MB, Johnson DH, Greco FA.
    J Clin Oncol; 1991 Oct; 9(10):1731-5. PubMed ID: 1919624
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.
    Jones SE, Mennel RG, Brooks B, Westrick MA, Allison MA, Paulson RS, Tilmann K, Rea B.
    J Clin Oncol; 1991 Oct; 9(10):1736-9. PubMed ID: 1919625
    [Abstract] [Full Text] [Related]

  • 3. Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
    Greco FA, Hainsworth JD.
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-61-S17-64. PubMed ID: 9374096
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trial.
    Hainsworth JD, Jones SE, Mennel RG, Blum JL, Greco FA.
    J Clin Oncol; 1996 May; 14(5):1611-6. PubMed ID: 8622079
    [Abstract] [Full Text] [Related]

  • 5. The use of mitoxantrone, 5-fluorouracil and high-dose leucovorin in the treatment of advanced breast cancer.
    Hainsworth JD.
    Ann Oncol; 1993 May; 4 Suppl 2():37-40. PubMed ID: 7688982
    [Abstract] [Full Text] [Related]

  • 6. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD, Jolivet J, Birch R, Hopkins LG, Greco FA.
    Cancer; 1997 Feb 15; 79(4):740-8. PubMed ID: 9024712
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.
    Repetto L, Miglietta L, Gardin G, Lanfranco C, Naso C, Merlini L, Giudici S, Venturino A, Campora E, Testore F.
    Breast Cancer Res Treat; 1994 Feb 15; 30(2):133-7. PubMed ID: 7949211
    [Abstract] [Full Text] [Related]

  • 8. Treatment of previously treated metastatic breast cancer by mitoxantrone and 48-hour continuous infusion of high-dose 5-FU and leucovorin (MFL): low palliative benefit and high treatment-related toxicity.
    Yen CC, Tung SL, Hsieh RK, Chiou TJ, Liu JH, Wang WS, Chen PM.
    Jpn J Clin Oncol; 1997 Oct 15; 27(5):316-20. PubMed ID: 9390208
    [Abstract] [Full Text] [Related]

  • 9. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience.
    Paul DM, Garrett AM, Meshad M, DeVore RD, Porter LL, Johnson DH.
    Semin Oncol; 1996 Feb 15; 23(1 Suppl 1):48-52. PubMed ID: 8629038
    [Abstract] [Full Text] [Related]

  • 10. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
    Colleoni M, Nelli P, Gaion F, Sgarbossa G, Manente P.
    Oncology; 1995 Feb 15; 52(6):435-8. PubMed ID: 7478426
    [Abstract] [Full Text] [Related]

  • 11. Salvage chemotherapy in metastatic breast cancer: an experience with the combination of mitoxantrone, 5-fluorouracil, and L-leucovorin.
    Colozza M, Gori S, Mosconi AM, Anastasi P, Basurto C, Ludovini V, De Angelis V, Giansanti M, Tonato M.
    Breast Cancer Res Treat; 1996 Feb 15; 38(3):277-82. PubMed ID: 8739080
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
    Klaassen U, Wilke H, Müller C, Borquez D, Harstrick A, Seeber S.
    Semin Oncol; 1997 Oct 15; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
    [Abstract] [Full Text] [Related]

  • 14. Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancer.
    Lorusso V, Mancarella S, Catino A, Brandi M, Paradiso A, Latorre A, Mastria A, De Mitrio A, Guida M, De Lena M.
    Tumori; 1999 Oct 15; 85(1):60-4. PubMed ID: 10228500
    [Abstract] [Full Text] [Related]

  • 15. Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and well-tolerated regimen for the treatment of advanced breast cancer.
    Wils JA.
    Eur J Cancer; 1993 Oct 15; 29A(15):2106-8. PubMed ID: 8297648
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mitoxantrone, fluorouracil, and L-folinic acid in anthracycline-pretreated metastatic breast cancer patients.
    Bascioni R, Giorgi F, Silva RR, Acito L, Giustini L, De Signoribus G, Giuliodori L, Testa E.
    Breast Cancer Res Treat; 1997 Sep 15; 45(3):205-10. PubMed ID: 9386863
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.